Ensign Peak Advisors’s Vir Biotechnology VIR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.94M | Buy |
582,981
+519,107
| +813% | +$2.62M | 0.01% | 782 |
|
|
2025
Q1 | $414K | Hold |
63,874
| – | – | ﹤0.01% | 1594 |
|
|
2024
Q4 | $469K | Hold |
63,874
| – | – | ﹤0.01% | 1616 |
|
|
2024
Q3 | $478K | Buy |
63,874
+13,600
| +27% | +$102K | ﹤0.01% | 1621 |
|
|
2024
Q2 | $447K | Hold |
50,274
| – | – | ﹤0.01% | 1630 |
|
|
2024
Q1 | $509K | Sell |
50,274
-2,536
| -5% | -$25.7K | ﹤0.01% | 1621 |
|
|
2023
Q4 | $531K | Buy |
52,810
+22,800
| +76% | +$229K | ﹤0.01% | 1646 |
|
|
2023
Q3 | $281K | Sell |
30,010
-147,691
| -83% | -$1.38M | ﹤0.01% | 1698 |
|
|
2023
Q2 | $4.36M | Hold |
177,701
| – | – | 0.01% | 626 |
|
|
2023
Q1 | $4.14M | Buy |
177,701
+63,511
| +56% | +$1.48M | 0.01% | 621 |
|
|
2022
Q4 | $2.89M | Buy |
114,190
+7,350
| +7% | +$186K | 0.01% | 698 |
|
|
2022
Q3 | $2.06M | Buy |
106,840
+38,151
| +56% | +$736K | 0.01% | 770 |
|
|
2022
Q2 | $1.75M | Sell |
68,689
-44,820
| -39% | -$1.14M | ﹤0.01% | 856 |
|
|
2022
Q1 | $2.92M | Buy |
113,509
+2,940
| +3% | +$75.6K | 0.01% | 735 |
|
|
2021
Q4 | $4.63M | Buy |
+110,569
| New | +$4.63M | 0.01% | 685 |
|
|
2020
Q4 | – | Sell |
-24,128
| Closed | -$829K | – | 1880 |
|
|
2020
Q3 | $829K | Buy |
24,128
+18,578
| +335% | +$638K | ﹤0.01% | 1385 |
|
|
2020
Q2 | $227K | Buy |
+5,550
| New | +$227K | ﹤0.01% | 1570 |
|